DecisionLine Clinical Research Overview
- Founded
- 1997
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
DecisionLine Clinical Research General Information
Description
Provider of clinical research services. The company specializes in conducting Phase I studies involving the measurement of pharmacodynamic effects of central nervous system (CNS) drugs
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Primary Office
- 720 King Street West
- Toronto, Ontario M5V 2T3
- Canada
DecisionLine Clinical Research Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore DecisionLine Clinical Research‘s full profile, request access.
Request a free trialDecisionLine Clinical Research Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Edward Sellers Ph.D | Founder, President & Chief Executive Officer |